Source: https://www.robinskaplan.com/resources/newsletters/generically-speaking-hatch-waxman-bulletin/generically-speaking-spring-2012
Timestamp: 2019-04-19 11:22:48+00:00

Document:
The Hatch-Waxman Litigation practice group at Robins Kaplan LLP is is proud to offer the latest edition of its quarterly publication concerning ANDA patent litigation issues and the generics business, GENERICally Speaking: Hatch-Waxman Litigation Bulletin.
Sciele Pharma. Inc. v. Lupin Ltd.
Adams Respiratory Therapeutics, Inc. v. Perrigo Co.
Sunovion Pharma., Inc. v. Dey Pharma., L.P.
Merck & Co., Inc. v. Sandoz, Inc.
Cephalon, Inc. v. Sandoz, Inc.
Dey, Inc. v. Sepracor, Inc.
Hoffman-La Roche Inc. v. Apotex, Inc.
Bone Care Int'l, LLC v. Pentech Pharma, Inc.
AstraZeneca Pharma. LP v. Anchen Pharma., Inc.

References: v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v. 
 v.